Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation

Christoph B. Olivier

Christoph B. Olivier: New DGK Consensus Recommendations on Switching Antiplatelet Therapies
Jul 7, 2026, 13:24 | Science
Christoph B. Olivier: New DGK Consensus Recommendations on Switching Antiplatelet Therapies
Christoph B. Olivier, Head of the Clinical Trials Unit, UHZ Freiburg, shared on LinkedIn about…
Pall T. Onundarson: The 3-Decade Journey of Ultrasound-Enhanced Fibrinolysis in PE
May 31, 2026, 10:32 | Science
Pall T. Onundarson: The 3-Decade Journey of Ultrasound-Enhanced Fibrinolysis in PE
Pall T. Onundarson, Professor Emeritus at Landspitali University Hospital, shared a post on LinkedIn about a…
Ben Creagh-Brown: How Should HI-PEITHO Influence the Management of Intermediate-Risk Pulmonary Embolism?
May 30, 2026, 08:58 | Science
Ben Creagh-Brown: How Should HI-PEITHO Influence the Management of Intermediate-Risk Pulmonary Embolism?
Ben Creagh-Brown, Consultant Physician at Royal Surrey County Hospital NHS Foundation Trust, shared a post…
Christoph B. Olivier: CYP2C19 Genotype, Platelet Reactivity and Risk Stratification in AF Patients Undergoing PCI 
May 19, 2026, 20:00 | Science
Christoph B. Olivier: CYP2C19 Genotype, Platelet Reactivity and Risk Stratification in AF Patients Undergoing PCI 
Christoph B. Olivier, Head of the Clinical Trials Unit, UHZ Freiburg, shared on LinkedIn about…
Fayad Al-Haimus։ HI-PEITHO Shows Reduced PE Complications Without Increased Bleeding
Apr 23, 2026, 16:12 | Voices
Fayad Al-Haimus։ HI-PEITHO Shows Reduced PE Complications Without Increased Bleeding
Fayad Al-Haimus, Adult Thrombosis Fellow at McMaster University, shared a post on LinkedIn about a recent…
Gregory Piazza: Ushering in a New Era in PE Therapy and Improved Clinical Outcomes for Our Patients
Apr 22, 2026, 07:46 | Science
Gregory Piazza: Ushering in a New Era in PE Therapy and Improved Clinical Outcomes for Our Patients
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared a…
Christoph B. Olivier: What If We Reduce Cardiovascular Collapse in PE by 60% Without Increasing Bleeding?
Mar 29, 2026, 06:11 | Science
Christoph B. Olivier: What If We Reduce Cardiovascular Collapse in PE by 60% Without Increasing Bleeding?
Christoph B. Olivier, Head of the Clinical Trials Unit, UHZ Freiburg, shared on LinkedIn about a…
Christoph B. Olivier: Annabel Hölzle Shared Critical Findings on HALT After TAVR
Mar 13, 2026, 22:05 | Voices
Christoph B. Olivier: Annabel Hölzle Shared Critical Findings on HALT After TAVR
Christoph B. Olivier, Head of the Clinical Trials Unit, UHZ Freiburg, shared on LinkedIn, adding:…
Christoph B. Olivier: New Research from Marius Wessinger on Predicting Therapy Success After Pulmonary Embolism
Mar 13, 2026, 20:11 | Insight
Christoph B. Olivier: New Research from Marius Wessinger on Predicting Therapy Success After Pulmonary Embolism
Christoph B. Olivier, Head of the Clinical Trials Unit, UHZ Freiburg, shared on LinkedIn, adding:…
Christoph B. Olivier: Celebrating the Transformative Impact of Women in Research
Mar 8, 2026, 10:57 | Voices
Christoph B. Olivier: Celebrating the Transformative Impact of Women in Research
Christoph B. Olivier, Head of the Clinical Trials Unit, UHZ Freiburg, shared on LinkedIn: ''The…
Christoph B. Olivier: Can We Stay Ahead of Valve Thrombosis?
Feb 13, 2026, 11:00 | Science
Christoph B. Olivier: Can We Stay Ahead of Valve Thrombosis?
Christoph B. Olivier, Head of the Clinical Trials Unit, UHZ Freiburg, shared RPTH Journal's post…
Christoph B Olivier's Team Explores Platelet Reactivity and Fibrin Clot-Strength in AF
Sep 27, 2025, 12:54 | Science
Christoph B Olivier's Team Explores Platelet Reactivity and Fibrin Clot-Strength in AF
Jan Hartmann, Chief Medical Officer at Haemonetics, reposted from Haemonetics on LinkedIn: ''Encouraging progress in…
All: 12 Posts: 1 - 100
NewsFeed